A new interactive map of the surface of SARS-CoV-2, featuring the Spike, Envelope and Membrane proteins, has been released for researchers to use.
List view / Grid view
Filter the results
Discover the possibilities opened up by HTRF cytokine assays in an autoimmune context.
Researchers have identified two molecules that explain why children experience COVID-19 differently to adults.
Scientists have found a hormone peptide called YY that presents a promising drug target for malabsorption in babies.
24 September 2020 | By PerkinElmer
.Join us on 12 November for our live webinar were two leading researchers will discuss their innovative approaches to developing novel opportunities for immunotherapy treatments.
Webinar: Optimised workflow for rapid identification of neutralising antibodies against viral particles
Helping in the race to identify effective neutralising antibodies against the spike protein of SARS-CoV-2 virus as the COVID-19 global death rate continues to rise.
The essential guide for extending your knowledge on the molecular mechanisms of neurodegenerative diseases
A pocket in the SARS-CoV-2 Spike protein has been discovered by researchers, who say it could be a drug target for COVID-19.
This review highlights 5 recent publications about homogeneous assays applied to PROTACs, a chemical knockdown approach for cancer research.
Many anti-angiogenic drugs have been developed to use in cancer therapy, while pro-angiogenic molecules may hold potential in regenerative applications.
Researchers report that removing the vSLFN gene from the ectromelia virus (ECTV) caused a potent immune response which protected animal models.
Scientists explore whether the anti-stress drug, 4-Phenylbutiric acid (4-PBA), could prevent cytokine storms causing respiratory failure in COVID-19 patients.